NDAT.CN nDatalyze (CNQ) +150% on high volume 19 Feb 2026: liquidity spike may signal trend change

The NDAT.CN stock surged 150.00% to C$0.05 on 19 Feb 2026 during market hours on the CNQ, driven by a volume spike of 268000.00 shares versus an average of 6677.00. Trading opened at C$0.03 and the intraday range hit C$0.05. The move comes without a public earnings announcement, so we assess liquidity, valuation and short-term catalysts to explain why volume mattered more than fundamentals today.

Price and volume: what the market action shows for NDAT.CN stock

Today NDAT.CN stock traded with 268000.00 shares, nearly 3.00x relative volume versus the 6,677.00 average. The jump from C$0.02 previous close to C$0.05 equates to a C$0.03 move and 150.00% intraday gain. High relative volume with a move to the year high (C$0.04) suggests short-term liquidity chasing rather than an earnings-driven re-rate.

Valuation and financials: ratios to watch

nDatalyze (NDAT.CN) shows compressed fundamentals: EPS -0.02, PE reported as -1.00 and PB ratio 1.65. Market cap stands at C$826,548.00 with 41,327,400.00 shares outstanding. Current ratio is 21.60, driven by low liabilities and cash per share 0.01. These metrics flag a microcap with weak earnings but decent balance-sheet liquidity.

Sector context and risks in Healthcare for NDAT.CN stock

NDAT.CN sits in Healthcare, Medical – Healthcare Information Services, a sector under pressure with average sector ROE near -3.77 in our dataset and average volatility higher than large caps. nDatalyze’s operational mix — mental health ML product plus extraction equipment — increases execution risk. The company lacks recent earnings announcements, which raises event risk when volume spikes occur.

Technical read and trading signals

Momentum indicators show mixed signals: RSI at 38.85 suggests no overbought condition, ADX 41.10 indicates a strong short-term trend, and OBV sits negative at -61,000.00, signalling prior selling pressure. Price averages show 50-day C$0.02 and 200-day C$0.02. For traders, the tight float and low free float liquidity amplify moves and risk.

Meyka grade and model forecast for NDAT.CN stock

Meyka AI rates NDAT.CN with a score out of 100: Meyka AI rates NDAT.CN with a score of 62.46 out of 100 and assigns a B / HOLD suggestion. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects monthly C$0.01 and quarterly C$0.02, versus the current price of C$0.05 implying downside to those short-term model points. Forecasts are model-based projections and not guarantees.

Catalysts and next steps for investors

Watch for company updates, licensing deals for the machine-learning mental health platform, or transaction news in the extraction equipment segment. With average volume at 6,677.00, a single block trade can swing price sharply. Risk management should include stop limits and position size limits because microcap volatility can erase gains quickly.

Final Thoughts

NDAT.CN stock’s 150.00% intraday surge to C$0.05 on 19 Feb 2026 is textbook high-volume microcap volatility: heavy relative volume (268,000.00) pushed price to a new short-term high without an earnings release. Valuation metrics show negative earnings (EPS -0.02) and a PE in negative territory, while a high current ratio (21.60) and modest cash per share provide a liquidity cushion. Meyka AI’s forecast model projects monthly C$0.01 and quarterly C$0.02, which implies downside of -80.00% and -60.00% versus today’s price; these figures are model-based projections and not guarantees. Traders should treat today’s move as a liquidity-driven event and demand clear operational catalysts before re-rating the company. For longer-term investors, focus on revenue traction for the mental health platform, license pipeline and any formal guidance. See the company site for filings and our live coverage on the Meyka stock page for real-time updates. Sources: Investing.com ZA comparison note and nDatalyze corporate site.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.